Verrica Pharmaceuticals (VRCA) Cash & Equivalents (2017 - 2026)
Verrica Pharmaceuticals (VRCA) posted Cash & Equivalents of $11.2 million for Q2 2026, down 27.3% from $15.4 million a year earlier and down 45.6% from the prior quarter.
Powered by 
Analysis
Verrica Pharmaceuticals (VRCA) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Verrica Pharmaceuticals' Cash & Equivalents came in at $30.15 million, down 34.9% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 23.1% (FY2020 to FY2025).
- In prior years, Verrica Pharmaceuticals' Cash & Equivalents was $46.33 million in FY2024 (-33.4%), $69.55 million in FY2023 (+102.9%), $34.27 million in FY2022 (+117.6%) and $15.75 million in FY2021 (+47.4%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents since Q4 2020.
- On a year-over-year basis, Cash & Equivalents has declined in each of the last ten quarters, with an average decline of 37.3% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q3 2023, with growth of 159.6%; the weakest was Q3 2024, with a decline of 72.7%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $20.6 million (Q1 2026), $30.15 million (Q4 2025) and $21.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Verrica Pharmaceuticals | 75.24 Mn | -7.80 Mn | - | 11.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.20 Mn |
| Mar 31, 2026 | 20.60 Mn |
| Dec 31, 2025 | 30.15 Mn |
| Sep 30, 2025 | 21.10 Mn |
| Jun 30, 2025 | 15.40 Mn |
| Mar 31, 2025 | 29.60 Mn |
| Dec 31, 2024 | 46.33 Mn |
| Sep 30, 2024 | 23.00 Mn |
| Jun 30, 2024 | 31.93 Mn |
| Mar 31, 2024 | 48.94 Mn |
| Dec 31, 2023 | 69.55 Mn |
| Sep 30, 2023 | 84.31 Mn |
| Jun 30, 2023 | 55.14 Mn |
| Mar 31, 2023 | 60.00 Mn |
| Dec 31, 2022 | 34.27 Mn |
| Sep 30, 2022 | 32.47 Mn |
| Jun 30, 2022 | 45.43 Mn |
| Mar 31, 2022 | 50.41 Mn |
| Dec 31, 2021 | 15.75 Mn |
| Sep 30, 2021 | 20.44 Mn |
API Access
Verrica Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VRCA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "VRCA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VRCA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();